Pfizer on Wednesday (PFE.N) said it will set the U.S. price for its COVID-19 antiviral treatment Paxlovid at nearly $1,400 per five-day course when it moves to commercial sales after government stocks run out.
Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease , is displayed in this picture illustration taken October 7, 2022. A morning and an evening does consists of one white 100-milligram tablet of Ritonavir and two pink 150-milligram tablets of PF-07321332. REUTERS/Wolfgang Rattay/Illustration/File Photosaid it will set the U.S.
The U.S. government paid around $530 per course for Paxlovid it has made available to Americans at no cost. The new list price before rebates and other discounts to insurers and pharmacy benefit managers is $1,390 per course, Pfizer said in an emailed statement. The United States purchased around 24 million courses of the oral two-drug treatment from Pfizer, and had still had a large supply, but arranged to return 7.9 million courses
Under that deal, a credit for the returned Paxlovid doses will pay for Pfizer to supply the pills at no charge to uninsured and underinsured Americans through 2028, and to patients insured under the government's Medicare and Medicaid programs through the end of next year.President Joe Biden's administration on Wednesday announced $3.5 billion in grants for projects to protect the aging U.S.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer Prices Covid Drug Paxlovid at $1,400 for a Five-Day CourseDrugmaker is expected to offer steep discounts to ensure wide access
Read more »
Price of lifesaving COVID-19 antiviral Paxlovid expected to rise next year, raising concerns about accessThe new price – the cost before insurance – hasn't been set but is expected to be higher than the $530-per-course price paid by the U.S. government.
Read more »
Pfizer and Moderna's updated COVID shots fully approved for people 12 and olderThe Pennsylvania Breast Cancer Coalition is celebrating 30 years.
Read more »
Government Reduces Paxlovid Stockpile, Returns Millions of DosesThe U.S. government has returned millions of doses of the COVID-19 antiviral medicine Paxlovid to its manufacturer.
Read more »
Pfizer agrees to pay $2M after allegations of wage discriminationThe company has not admitted involvement in wage discrimination and said it agreed to the resolution 'due to the amount of time that has transpired.'
Read more »